Upcoming event


5α-Reductase inhibitors, Aanticoagulants, Antegrade ejaculation, Aquablation, Avanafil, Benign Prostatic Diseases, bipolar TURO, Bladder injury, Bladder outlet obstruction, Bladder trauma, BNC, BOO, BOOI, BPD, BPE, BPH, BPO, Chronic bacterial prostatitis, CP/CPPS, CPPS, Desmopressin, Detrusor, Detrusor hypocontractility, Dihydrotestosterone, Drug adherence, Drug therapy, Dutasteride, EAU, Ejaculation, Ejaculation preservation, Ejaculatory dysfunction, Endoscopic surgery, Epidemiology, Erectile dysfunction, Fexapotide triflutate, Fibrosis, Finasteride, Frequency volume chart, GL-XPS, GreenLight laser, Guidelines, Herbal medicines, HoLEP, Hypogonadism, Impaired contractility, Incontinence, Infertility, Inflammation, Inflammatory biomarkers, Innervation, IPP, IPSS, iTIND, Laparoscopy, Laser Bipolar, Laser prostatectomy, Laser therapy, LUT, LUTS, Major cardiac adverse event, Management of Non-Neurogenic LUTS incl. BPO, Medical therapy, Meta analysis, Meta regression, Metabolic syndrome, Microbiome, Micturition chart, Minimally invasive surgical therapy, minimally invasive techniques, Mirabegron, Monotherapies, Muscarinic antagonist, nitinol, Nocturia, Noninvasive, NX-1207, Overactive bladder, Pathogenesis, Pathophysiology, Patient satisfaction, Patient-reported outcome, Permixon, Pharmacology, Phenotypically directed multimodal management, Phosphodiesterase type 5 inhibitor, Phosphodiesterase type 5 inhibitors, Phytotherapy, Placebo effect, Plasmakinetic enucleation, Prospective study, Prostate, Prostate arterial embolisation, Prostate surgery, Prostate-specific antigen, Prostatectomy, Prostatic, Prostatic arterial embolization, Prostatic artery embolization, Prostatic hyperplasia, Prostatitis, PUL, Quality of life, Randomized trial, RASP, Remission, Retrograde ejaculation, Robotic, Robotic surgery, Robotics, Serenoa repens, Sexual Dysfunction, Sexual dysfunctions, Sildenafil, Simple prostatectomy, Solifenacin, Stem cells, Surgery, Surgical intervention, Systematic review, Tadalafil, Tamsulosin, Telomerase, Testosterone, ThuLEP, TmLRP, TUR syndrome, TURis, TURP, Ultrasonography, Underactive bladder, urethral implantable device, Urethral injury, Urethral trauma, Urinary Incontinence in Adults, Urinary nerve growth factor, Urinary sphincter, Urodynamics, Urolift, Vardenafil, Voiding, Voiding dysfunction, α-Adrenergic blocker, α-Adrenoceptor antagonists, α-Blocker, α-blockers, α1-Blockers
Show all

Holmium laser enucleation vs bipolar plasmakinetic enucleation of a large volume benign prostatic hyperplasia: a randomized controlled trial

Journal of Endourology, Volume 34, Issue 3, March 2020

Predictive factors of urinary incontinence after holmium laser enucleation of the prostate: a multicentric evaluation

World Journal of Urology, March 2020

Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: a randomized, placebo-controlled study (MATCH)

European Urology Focus, November 2020

Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo

European Urology, January 2020

A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study)

Neurourology and urodynamics, February 2020

Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR)

BMC Geriatrics, March 2020

High real-world medication adherence and durable clinical benefit in medicare patients treated with 5 alpha-reductase inhibitors for benign prostatic hyperplasia

Journal of Urology, March 2020

Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta‐3 agonist: a population‐based cohort study

BJU International, March 2020

Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia

European Urology, December 2020

An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia

World Journal of Urology, December 2020

State of the art of thulium laser enucleation and vapoenucleation of the prostate: a systematic review

Urology, Volume 136, February 2020, Pages 19-34

Efficacy and safety of mirabegron versus placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: A randomized, phase 4 study (PLUS)

The journal of urology, January 2020